NQCFX
Price
$26.41
Change
-$0.50 (-1.86%)
Updated
Jun 13 closing price
Net Assets
8.56M
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

NQCFX vs RGAGX

Header iconNQCFX vs RGAGX Comparison
Open Charts NQCFX vs RGAGXBanner chart's image
NorthQuest Capital
Price$26.41
Change-$0.50 (-1.86%)
VolumeN/A
Net Assets8.56M
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
NQCFX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NQCFX vs. RGAGX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQCFX is a Hold and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. NQCFX (8.56M). RGAGX pays higher dividends than NQCFX: RGAGX (0.65) vs NQCFX (0.00). NQCFX was incepted earlier than RGAGX: NQCFX (23 years) vs RGAGX (16 years). NQCFX (1.42) is less costly to investors than RGAGX (0.30). RGAGX is a more actively managed with annual turnover of: 25.00 vs. NQCFX (11.05). RGAGX has a lower initial minimum investment than NQCFX: RGAGX (250) vs NQCFX (1000). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. NQCFX (3.73). RGAGX return over 5 years is better than : 51.11 vs. NQCFX (40.25).
NQCFXRGAGXNQCFX / RGAGX
Total Expense Ratio1.420.30473%
Annual Report Gross Expense Ratio1.420.30473%
Fund Existence23 years16 years-
Gain YTD0.9565.20518%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.56M306B0%
Annual Yield % from dividends0.000.65-
Returns for 1 year3.737.6749%
Returns for 3 years37.7754.6669%
Returns for 5 years40.2551.1179%
Returns for 10 years69.5175.6292%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo